Current Drug Discovery Technologies
Title:Meet Our Section Editor
Volume: 17 Issue: 3
Author(s): Masami Ishido
Affiliation:
Export Options
About this article
Cite this article as:
Ishido Masami , Meet Our Section Editor, Current Drug Discovery Technologies 2020; 17 (3) . https://dx.doi.org/10.2174/157016381703200715115502
DOI https://dx.doi.org/10.2174/157016381703200715115502 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
Related Books
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Obesity: Genetics, Behavior or a Combination of Both
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation- Mediated Sensory and Motor Dysfunction in A Rat Model of Compression Spinal Cord Injury
Current Molecular Pharmacology Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation
Current Neurovascular Research Machine Learning Study of Classifiers Trained with Biophysiochemical Properties of Amino Acids to Predict Fibril Forming Peptide Motifs
Protein & Peptide Letters Proteolytic Degradation of the Amyloid β-Protein: The Forgotten Side of Alzheimers Disease
Current Alzheimer Research Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Carbon Monoxide-Releasing Molecules: A Pharmacological Expedient to Counteract Inflammation
Current Pharmaceutical Design Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin
Current Gene Therapy Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Current Neuropharmacology Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Current Alzheimer Research Tetraplex Binding Molecules as Anti-Cancer Agents
Recent Patents on Anti-Cancer Drug Discovery Natural Polyphenols in the Treatment of Alzheimer’s Disease
Current Drug Targets Function of Cytosolic Chaperones in Tom70-Mediated Mitochondrial Import
Protein & Peptide Letters Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases
Current Pharmaceutical Design A Review of Patent Literature for Iontophoretic Delivery and Devices
Recent Patents on Drug Delivery & Formulation Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease
Current Drug Metabolism Structure, Function, and Signaling of Taste G-Protein-Coupled Receptors
Current Pharmaceutical Biotechnology Chemogenomics of Sensitivity and Resistance to Anticancer Drugs
Current Pharmacogenomics Flavonoids and its Neuroprotective Effects on Brain Ischemia and Neurodegenerative Diseases
Current Drug Targets